Publication | Open Access
An Open-Label Study of the Long-Term Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (RECAP)
147
Citations
11
References
2017
Year
RECAP provides long-term follow-up and safety data for pirfenidone that were consistent with the known profile, with no new safety signals observed.
| Year | Citations | |
|---|---|---|
Page 1
Page 1